A case of chronic and progressive distal symmetric type CIDP with subacute exacerbation: Focus on clinical pattern of CIDP

Clinical Neurology

Volumn 51, Issue 2, 2011, Pages 141-144

  Shibuya, Kazumoto ^a   Misawa, Sonoko ^a   Fukushima, Takeshi ^a   Uchiyama, Tomoyuki ^a   Funakoshi, Kei ^b   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Demyelinating acquired distal symmetric neuropathy; Plasmapheresis

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; LATENT PERIOD; LIMB DYSESTHESIA; LIMB WEAKNESS; MALE; NERVE CONDUCTION; PLASMAPHERESIS; REMISSION;

EID: 79952549258     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.51.141     Document Type: Article

References (8)

1. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005;10:220-228.
2. Katz JS, Saperstein DS, Gronseth G, et al. Distal acquired demyelinating symmetric neuropathy. Neurology 2000;54:615-620.
3. Tagawa Y, Yuki N, Hirata K. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG / SGPG antibody-associated neuropathy. Muscle Nerve 2000;23:895-899. (Pubitemid 30354496)
4. Hadden RD, Nobile-Orazio E, Sommer C, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:809-818.
5. Nobile-Orazio E, Meucci N, Baldini L, et al. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000;123:710-717. (Pubitemid 30162720)
6. Oksenhendler E, Chevret S, Léger JM, et al. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry 1995;59:243-247.
7. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991;325:1482-1486.
8. Kuwabara S, Ogawara K, Misawa S, et al. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002;72:37-42. (Pubitemid 34073093)